Best Practice & Research Clinical Rheumatology
Volume 20, Issue 3 , Pages 487-505, June 2006

Uveitis

  • Santiago Muñoz-Fernández, MD, PhD (Professor of Medicine)

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: Servicio de Reumatología, Hospital Universitario La Pas, Paseo de la Castellana 261, 28046 Madrid, Spain. Tel.: +34 91 7277193; fax: +34 91 7292794.
  • ,
  • Emilio Martín-Mola, MD, PhD (Professor of Medicine)

Rheumatology Unit, Hospital Universitario La Pas, Universidad Autónoma de Madrid, Madrid, Spain

Uveitis is a prevalent disease that mainly affects young people. It leads to a significant number of visual losses. Acute anterior uveitis is the most prevalent form, and it is often associated with spondyloarthritides in which uveitis can be the first manifestation of disease. Precise patterns of uveitis are frequently associated with systemic diseases. Thus, the close collaboration between ophthalmologists and rheumatologists avoids unnecessary diagnostic tests and is essential for the correct assessment and treatment of these patients. Acute anterior uveitis usually has a good prognosis compared with other forms of uveitis. However, it is a cause of disability when flares are frequent. Small prospective studies conducted with sulphasalazine have demonstrated a reduction in the number of flares. Other patterns of uveitis have a worse prognosis, and systemic corticosteroids and/or immunosuppressive drugs are usually required. Infliximab is a promising therapeutic option in selected patients.

Key words: uveitis, uveitis anterior, spondyloarthritides, spondyloarthritis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(06)00038-6

doi:10.1016/j.berh.2006.03.008

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 3 , Pages 487-505, June 2006